HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 33 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $466,000 | -85.9% | 1,411,500 | -69.2% | 0.23% | -85.4% |
| Q2 2020 | $3,297,000 | +127.7% | 4,579,500 | +2.8% | 1.56% | +75.9% |
| Q1 2020 | $1,448,000 | -3.5% | 4,455,500 | +108.4% | 0.88% | +28.9% |
| Q4 2019 | $1,501,000 | +2174.2% | 2,137,900 | +2037.9% | 0.69% | +1917.6% |
| Q3 2019 | $66,000 | +288.2% | 100,000 | +900.0% | 0.03% | +325.0% |
| Q2 2019 | $17,000 | -66.0% | 10,000 | -50.0% | 0.01% | -69.2% |
| Q1 2019 | $50,000 | – | 20,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,280,185 | $9,755,000 | 1.01% |
| Cormorant Asset Management, LP | 201,000 | $1,532,000 | 0.24% |
| PUTNAM INVESTMENTS LLC | 575,692 | $4,386,000 | 0.01% |
| Alyeska Investment Group, L.P. | 114,113 | $870,000 | 0.01% |
| VANGUARD GROUP INC | 4,355,424 | $131,473,000 | 0.01% |
| BLACKROCK ADVISORS LLC | 463,200 | $3,530,000 | 0.00% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 26,100 | $199,000,000 | 0.00% |
| Ironwood Financial, llc | 870 | $7,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 24,293 | $185,000 | 0.00% |
| Sonora Investment Management, LLC | 500 | $3,000 | 0.00% |